-
Enanta CFO dies after taking medical leave of absence
03 Sep 2025 22:15 GMT
…
Harry R. Trout, III, Enanta’s vice president of finance … LinkedIn profile.
Mellett joined Enanta in September 2003 and established … Wednesday release. He led Enanta’s initial public offering in 2013 and was … said.
Prior to joining Enanta, he was senior vice …
-
Enanta Pharmaceuticals Announces the Passing of its Beloved and Respected Longtime Chief Financial and Administrative Officer Paul J. Mellett Jr.
03 Sep 2025 10:51 GMT
… 3, 2025--
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) today announced … success. He led Enanta’s Initial Public Offering in 2013 and … basis.
About Enanta Pharmaceuticals, Inc.
Enanta is using … PHARMACEUTICAL SCIENCE
SOURCE: Enanta Pharmaceuticals, Inc.
Copyright …
-
Covid-19 Pill Developer to Spend SPAC IPO Funds on Clinical Trial, Hiring
12 Jan 2022 12:48 GMT
…
Pfizer Inc.,
Watertown, Mass.-based
Enanta Pharmaceuticals Inc.
and Japanese drugmaker … time frame through a traditional IPO, she said. “We received the … SPACs, to bypass the traditional IPO process and gain a public …
-
The Week Ahead in Biotech (Nov. 7–Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs, and More
10 Nov 2021 13:45 GMT
… ;Presentations
Liver Meeting Presentations
Enanta Pharmaceuticals, Inc.: Phase … before the market open)
IPOs
IPO Pricing
Dallas, Texas- … common stock in an initial public offering, The offering is expected … ticker symbol “VAXX.”
IPO Quiet Period Expiry
Bone …
-
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
08 Nov 2021 13:38 GMT
… Meeting Presentations
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA): Phase 1b … (before the market open)
IPOs
IPO Pricing
Dallas, Texas-based … common stock in an initial public offering, The offering is expected … "VAXX."
IPO Quiet Period Expiry
Bone …
-
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
08 Oct 2021 11:49 GMT
… Incorporated (NASDAQ: CYTK)
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA)
Legend Biotech Corporation (NASDAQ … follow up.
IPOs
IsoPlexis Corporation (NASDAQ: ISO) priced its initial public offering of 8 … Arix Bioscience plc, priced its IPO of 10.5 million shares …
-
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
01 Aug 2021 14:49 GMT
… pelabresib in myelofibrosis
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA): Phase 1 … NBRV) (after the close)
Enanta Pharma (after the close)
… IPOs
IPO Pricing
Philadelphia, Pennsylvania-based Context Therapeutics, Inc. is planning an initial public offering …
-
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
06 Feb 2021 23:35 GMT
… the market close)
Enanta Pharmaceuticals Inc (NASDAQ: ENTA) (after the market … (before the market open)
IPOs
Adagene, Inc., a China- … ordinary shares, in an initial public offering. The company expects to … 7.53-million-share IPO, with the offering estimated …
-
The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs
06 Feb 2020 12:52 GMT
… ) (after the close)
Enanta Pharmaceuticals Inc (NASDAQ: ENTA) (after the close)
Myriad … close)
IPO
Beam Therapeutics said it has priced its upsized initial public offering of … priced its 60-million share IPO at $27 compared to the …
About
© 1995-2025